Adrenocortical suppression following treatment with beclomethasone and budesonide
- 1 January 1991
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 21 (1), 145-146
- https://doi.org/10.1111/j.1365-2222.1991.tb00817.x
Abstract
The study was carried out to compare the adrenocortical suppression caused by inhaled beclomethasone dipropionate (BDP) with the suppression caused by budesonide (Bu). The study was of an open cross-over design. Sixteen children with asthma were treated with high-dose inhaled BDP and Bu via a 750 ml spacer (Nebuhaler). Each drug was used for periods of 6 weeks. The 24-hr urinary cortisol excretion was unchanged in 11 subjects. A reproducible suppression of the urinary cortisol excretion was shown in three subjects following BDP and in two subjects following treatment with Bu. The results of the study indicate the occurrence of interpersonal variations of the sensitivity to the adrenocortical suppressive effect of BDP and Bu.Keywords
This publication has 5 references indexed in Scilit:
- Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasoneEuropean Respiratory Journal, 1988
- Adrenocortical function in children on high‐dose steroid aerosol therapyAllergy, 1987
- Decreased adreno‐cortical suppression utilizing the Nebuhaler for inhalation of steroid aerosolsClinical and Experimental Allergy, 1987
- Comparison of budesonide and beclomethasone dipropionate for treatment of asthma.Archives of Disease in Childhood, 1987
- Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.Thorax, 1986